Share Name Share Symbol Market Type Share ISIN Share Description
Assura Plc LSE:AGR London Ordinary Share GB00BVGBWW93 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.20 0.26% 77.70 77.60 77.90 79.40 77.10 78.60 4,225,385 16:35:24
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Food & Drug Retailers 111.5 78.9 3.3 23.5 2,062

Assura PLC Trading update

02/04/2020 7:00am

UK Regulatory (RNS & others)

Assura (LSE:AGR)
Historical Stock Chart

From Mar 2020 to May 2020

Click Here for more Assura Charts.


RNS Number : 4923I

Assura PLC

02 April 2020

2 April 2020

Assura plc

Trading Update

For the fourth quarter ending 31 March 2020

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the fourth quarter ending 31 March 2020.

Jonathan Murphy, CEO, said:

"Assura is working closely with the NHS and our GP partners to make sure we can best support the health service through the Covid-19 crisis. We are also assisting occupiers to optimise the use of space in their buildings and offering vacant space to the NHS where we can. We are continuing to follow closely the latest advice of the Government and Public Health England, working with the contractors for our on-site developments.

"Looking at the quarter as a whole, Assura continued to make good operational progress, in particular around our acquisition and development opportunities, as we seek to deliver primary care assets that cater to the needs of the NHS now and for the future."

Covid-19 update

-- The safety and wellbeing of Assura's colleagues, tenants and patients who visit our primary care centres are our top priority.

-- We are working closely with the NHS and our GP tenants to discuss how we can help the health service; a ssisting tenants to make best use of space available in their buildings for temporary use in additional consulting, testing and respiratory care and offering vacant space to the NHS.

-- We are supporting contractors to follow Government advice for construction sites and prioritise the health of their teams and are prepared for delays to anticipated completion dates for our on-site developments and start dates of the immediate pipeline.

   --    March quarter rents being received in line with normal patterns. 

-- Dividend of 0.697 pence to be paid on 15 April 2020 as previously announced (ex-div date 12 March 2020).

Active fourth quarter

   --    Development at Knebworth completed and three schemes progressed to on-site. 
   --    13 acquisitions completed for combined GBP54 million, including GBP41 million in March. 

-- One disposal completed for GBP0.8 million and contracts exchanged for the disposal of 20 properties for total consideration of GBP17 million; expected to complete in the next few weeks.

Strong performance in the year

   --    Portfolio expanded to 576 properties with current annualised rent roll of GBP108.9 million. 
   --    Four developments completed in the year at a total cost of GBP14.8 million. 
   --    15 developments currently on site with a total cost of GBP81 million. 
   --    Acquisitions for the year total 28 for consideration of GBP119 million. 

-- 32 lease re-gears completed in the year representing GBP2.9 million of the Group's rent roll, adding a weighted average of 10.5 years WAULT to those leases.

Pipeline for future growth

-- Immediate development pipeline totalling GBP77 million, schemes which we expect to be on site within 12 months.

-- Immediate acquisitions pipeline stands at GBP67 million, which we would normally expect to complete in three-six months.

   --    Total immediate pipeline, including on site developments, worth GBP225 million. 

-- 38 lease re-gears agreed and currently in legal hands covering GBP4.6 million of existing rent roll.

-- There is an increased risk of delays in the timing of all pipelines due to Covid-19 and we continue to monitor the situation closely.

Robust balance sheet

-- As at 31 March 2020 gross debt stood at GBP847 million with undrawn facilities of GBP220 million.


For further information, please contact:

   Assura plc:                          Tel: 01925 420 660 
   Jayne Cottam, CFO 
   David Purcell, Head of Financial 
   Finsbury:                            Tel: 0207 251 3801 
   Gordon Simpson 
   James Thompson 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2019, Assura's property portfolio was valued at GBP2,039 million.

Further information is available at

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit



(END) Dow Jones Newswires

April 02, 2020 02:00 ET (06:00 GMT)

1 Year Assura Chart

1 Year Assura Chart

1 Month Assura Chart

1 Month Assura Chart
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20200527 00:58:40